AI Verdict
MRK has stronger fundamentals based on our AI analysis.
ABT vs MRK Fundamental Comparison
| Metric | ABT | MRK |
|---|---|---|
| Revenue | $44.3B | $65.0B |
| Net Income | $6.5B | $18.3B |
| Net Margin | 14.7% | 28.1% |
| ROE | 12.5% | 34.7% |
| ROA | 7.5% | 13.3% |
| Current Ratio | 1.58x | 1.54x |
| Debt/Equity | 0.25x | 0.89x |
| EPS | $3.72 | $7.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs MRK: Frequently Asked Questions
Is ABT or MRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MRK has stronger fundamentals. ABT is rated BUY (77% confidence) while MRK is rated BUY (80% confidence). This is not investment advice.
How does ABT compare to MRK fundamentally?
ABBOTT LABORATORIES has ROE of 12.5% vs Merck & Co., Inc.'s 34.7%. Net margins are 14.7% vs 28.1% respectively.
Which stock pays higher dividends, ABT or MRK?
ABT has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or MRK for long term?
For long-term investing, consider that ABT has BUY rating with 77% confidence, while MRK has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs MRK, the AI consensus favors MRK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.